Tesamorelin

Tesamorelin is a synthetic analog of human growth hormone-releasing hormone (GHRH 1-44) in which the N-terminal tyrosine residue carries a trans-3-hexenoic acid (hexenoyl) modification. This acylation is intended to confer resistance to enzymatic degradation relative to native GHRH, making the molecule a useful tool for studying the GHRH receptor and downstream signaling in controlled in vitro and ex vivo systems. The peptide is supplied as a lyophilized powder for laboratory research use only.

As a member of the growth hormone secretagogue class, Tesamorelin is used in research settings to investigate the regulation of the somatotropic axis and pulsatile growth hormone release at the cellular and receptor level. It serves as a reference compound in structure-activity studies of GHRH analogs and in assays probing peptide stability, receptor binding kinetics, and second-messenger pathways. All characterization data are provided to support analytical and method-development work.

Store lyophilized powder at -20C protected from light and moisture; stable for long-term storage. After reconstitution, store at 2-8C and use within a limited period; avoid repeated freeze-thaw cycles.

Reconstitute in sterile bacteriostatic or distilled water; the lyophilized peptide is readily soluble in aqueous buffer. Aliquot reconstituted stock to minimize freeze-thaw exposure. For laboratory research use only; not for human or veterinary use.